Effects of transtympanic intermittent pressure therapy using a new tympanic membrane massage device for intractable Meniere's disease and delayed endolymphatic hydrops: a prospective study.
Adult
Aged
Endolymphatic Hydrops
/ therapy
Female
Humans
Male
Meniere Disease
/ therapy
Middle Aged
Nystagmus, Pathologic
/ etiology
Otolaryngology
/ instrumentation
Prospective Studies
Retrospective Studies
Sick Leave
/ statistics & numerical data
Transtympanic Micropressure Treatment
Vertigo
/ etiology
Meniere’s disease
Meniett device
delayed endolymphatic hydrops
intractable vertigo
new tympanic membrane massage device
Journal
Acta oto-laryngologica
ISSN: 1651-2251
Titre abrégé: Acta Otolaryngol
Pays: England
ID NLM: 0370354
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
pubmed:
15
9
2021
medline:
9
2
2022
entrez:
14
9
2021
Statut:
ppublish
Résumé
The retrospective study showed that the effect of the middle ear pressure treatment by the tramstympanic membrane massage (TMM) device was similar to that of the Meniett device. The new TMM device named EFET device was prospectively evaluated in patients with Meniere's disease (MD) and delayed endolymphatic hydrops (DEH) and we compared the effects to the Meniett device. 23 ears of 19 patients were treated with an EFET device, and 17 ears of 15 patients were treated with the Meniett device. All patients suffering from intractable MD and DEH were treated for 4 months. The insertion of a transtympanic ventilation tube was necessary for the Meniett device, but not the EFET device. In patients treated by the EFET and Meniett devices, the frequency of vertigo significantly improved after treatment. The distribution of vertigo outcomes at 4 months after treatment did not differ between patients treated with the both devices. Middle ear pressure treatment by the EFET device is effective and provides minimally invasive options for intractable MD and DEH like the Meniett device.
Sections du résumé
BACKGROUND
BACKGROUND
The retrospective study showed that the effect of the middle ear pressure treatment by the tramstympanic membrane massage (TMM) device was similar to that of the Meniett device.
OBJECTIVES
OBJECTIVE
The new TMM device named EFET device was prospectively evaluated in patients with Meniere's disease (MD) and delayed endolymphatic hydrops (DEH) and we compared the effects to the Meniett device.
MATERIALS AND METHODS
METHODS
23 ears of 19 patients were treated with an EFET device, and 17 ears of 15 patients were treated with the Meniett device. All patients suffering from intractable MD and DEH were treated for 4 months. The insertion of a transtympanic ventilation tube was necessary for the Meniett device, but not the EFET device.
RESULTS
RESULTS
In patients treated by the EFET and Meniett devices, the frequency of vertigo significantly improved after treatment. The distribution of vertigo outcomes at 4 months after treatment did not differ between patients treated with the both devices.
CONCLUSIONS AND SIGNIFICANCE
CONCLUSIONS
Middle ear pressure treatment by the EFET device is effective and provides minimally invasive options for intractable MD and DEH like the Meniett device.
Identifiants
pubmed: 34520288
doi: 10.1080/00016489.2021.1942979
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM